Indication
Hypovolemic Shock
3 clinical trials
3 products
Product
CenthaquineClinical trial
A Prospective, Multi-centric, Open-labeled, Phase-IV Study to Assess Safety and Efficacy of LYFAQUIN™ (Centhaquine Citrate) as a Resuscitative Agent for Hypovolemic Shock to be Used as an Adjuvant to Standard Treatment of ShockStatus: Recruiting, Estimated PCD: 2025-11-01
Product
Normal SalineClinical trial
A Multi-Centric, Randomized, Double-Blind, Placebo-controlled, Phase-III Study to Assess Safety and Efficacy of Centhaquine as a Resuscitative Agent to be Used as an Adjuvant to Standard Treatment of Hypovolemic ShockStatus: Not yet recruiting, Estimated PCD: 2025-10-01
Clinical trial
Early Initiated Vasopressor Therapy vs. Standard Care of Primarily Fluid Therapy in Hypotensive Patients in the Emergency Department - A Pragmatic, Multi-center, Superiority, Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2025-12-31
Product
Noradrenaline